Abstract: A composition includes a polysaccharide at least one retinoid linked to at least one monosaccharide subunit of the polysaccharide with a covalent linkage. The linkage being degradable by hydrolysis during digestion of the composition to provide controlled, delayed, and/or sustained delivery of the at least one retinoid upon enteral administration of the composition to a subject.

Abstract: A molecular probe includes the following formula: P-L-C wherein P is a EDB-FN targeting peptide, C is a contrast agent; and L is a non-peptide linker that covalently links the peptide to the contrast agent.

Abstract: A plug connector includes: an insulative housing including a main body, a reinforcement projecting forward from the main body, and a pair of baffle plates; and a printed circuit board partially received in the insulative housing, the printed circuit board extending forward from the main body and beyond the reinforcement, the reinforcement wrapping on the printed circuit board, wherein a width of a front end of the printed circuit board exposed outside the main body in a horizontal direction is greater than a width of the reinforcement, and a limiting groove is formed between the baffle plate and the printed circuit board for guiding the plug connector to mate with a socket connector.

Abstract: A plug connector used to mate with the socket connector includes: a housing; a printed circuit board received in the housing, the circuit print board having plural soldering points; and a cable electrically connected to the soldering points of the printed circuit board, wherein the soldering points are provided with glue blocks to protect a connection between the printed circuit board and the cable.

Abstract: A nanosized complex includes a nucleic acid and a compound comprising formula (I): wherein R1 is an alkylamino group or a group containing at least one aromatic group; R2 and R3 are independently an aliphatic group or hydrophobic group; R4 and R5 are independently H, a substituted or unsubstituted alkyl group, an alkenyl group, an acyl group, or an aromatic group, or a polymer, a targeting group, a detectable moiety, or a linker, or a combination thereof, and at least one of R4 and R5 includes a retinoid or retinoid derivative that targets and/or binds to an interphotoreceptor retinoid binding protein; a, b, c, and d are independently an integer from 1 to 10; and pharmaceutically acceptable salts thereof.

Abstract: A compound comprising formula (I): wherein R1 is an alkylamino group or a group containing at least one aromatic group; R2 and R3 are independently an aliphatic group or hydrophobic group; R4 and R5 are independently H, a substituted or unsubstituted alkyl group, an alkenyl group, an acyl group, or an aromatic group, or includes a polymer, a targeting group, or a detectable moiety, and at least one of R4 and R5 includes a targeting group that targets and/or binds to a retinal or visual protein; a, b, c, and d are independently an integer from 1 to 10; and pharmaceutically acceptable salts thereof.

Abstract: An electrical connector includes: a connector unit having a mating part, the mating part defining a front mating end; a sleeve enclosing the mating part and extending forwardly beyond the front mating end to define a receiving chamber; and an outer cover enclosing the sleeve and the connector unit, wherein the sleeve has a front portion containing the receiving chamber, and the outer cover is made of a material softer than the sleeve.

Abstract: A compound includes at least one targeting peptide coupled to a detectable moiety. The targeting peptide binds to EDB-FN or EDA-FN and includes at least one of amino acid sequence selected from the group consisting of SEQ ID NOs: 1-30.

Abstract: A pharmaceutical composition includes a retinylamine derivative having the following formula: where R1 is an amino acid residue, a dipeptide or a tripeptide that is linked to the retinylamine by an amide bond.

Abstract: A nanosized complex includes siRNA and a compound comprising formula (I):

Abstract: A pharmaceutical composition includes a retinylamine derivative having the following formula (I): where R1 is an amino acid residue, a dipeptide or a tripeptide that is linked to the retinylamine by an amide bond.

Abstract: A compound includes at least one targeting peptide coupled to a detectable moiety. The targeting peptide binds to EDB-FN or EDA-FN and includes at least one of amino acid sequence selected from the group consisting of SEQ ID NOs: 1-30.

Abstract: A projecting unit includes a first light-source unit, a first digital micro-mirror unit, a second light-source unit, a second digital micro-mirror unit, a first prism, a first wide-angle lens, and a second wide-angle lens. The first light-source unit is configured to provide a first light beam. The first digital micro-mirror unit is configured to receive the first light beam and transform the first light beam into a first image signal. The second light-source unit is configured to provide a second light beam. The second digital micro-mirror unit is configured to receive the second light beam and transform the second light beam into a second image signal. The first prism is configured to receive and reflect the first and second image signals. The first wide-angle lens and the second wide-angle lens are configured to receive and project the first and second image signals reflected from the first prism respectively.

Abstract: A technique facilitates the anchoring and use of a downhole tool. The technique may be utilized with operations in which fluid is pumped or otherwise flowed through a tubular to the downhole tool. The operations are performed after the downhole tool has been fixed relative to the wellbore and while the tubular remains connected to the downhole tool. In some operations, the downhole tool is manipulated from the surface via the tubular to control placement of the fluid flowing down through the tubular.

Abstract: A composition includes a polysaccharide at least one retinoid linked to at least one monosaccharide subunit of the polysaccharide with a covalent linkage. The linkage being degradable by hydrolysis during digestion of the composition to provide controlled, delayed, and/or sustained delivery of the at least one retinoid upon enteral administration of the composition to a subject.

Abstract: A compound comprising formula (I): wherein R1 is an alkylamino group or a group containing at least one aromatic group; R2 and R3 are independently an aliphatic group or hydrophobic group; R4 and R5 are independently H, a substituted or unsubstituted alkyl group, an alkenyl group, an acyl group, or an aromatic group, or includes a polymer, a targeting group, or a detectable moiety, and at least one of R4 and R5 includes a targeting group that targets and/or binds to a retinal or visual protein; a, b, c, and d are independently an integer from 1 to 10; and pharmaceutically acceptable salts thereof.

Abstract: A composition includes a polysaccharide at least one retinoid linked to at least one monosaccharide subunit of the polysaccharide with a covalent linkage. The linkage being degradable by hydrolysis during digestion of the composition to provide controlled, delayed, and/or sustained delivery of the at least one retinoid upon enteral administration of the composition to a subject.

Abstract: A cable connector assembly includes: an insulative base (1); plural contacts secured to the insulative base, each contact having a contacting portion, a terminating portion, and a securing portion between the contacting portion and the terminating portion; a cable including plural wires connected to the contacts, each wire having a center conductor; and an outer shell enclosing the insulative base and a part of the cable; wherein the contact terminating portion has a groove (2021) receiving the cable wire center conductor; and the cable wire center conductor extends to terminate perpendicularly to an associated contact. Plural interconnecting pieces each secured to an associated cable wire center conductor are also designed to replace direct connection of the cable wires to the contacts.

Abstract: A compound includes at least one targeting peptide coupled to a detectable moiety. The targeting peptide binds to EDB-FN or EDA-FN and includes at least one of amino acid sequence selected from the group consisting of SEQ ID NOs: 1-30.

Abstract: A projecting unit includes a first light-source unit, a first digital micro-mirror unit, a second light-source unit, a second digital micro-mirror unit, a first prism, a first wide-angle lens, and a second wide-angle lens. The first light-source unit is configured to provide a first light beam. The first digital micro-mirror unit is configured to receive the first light beam and transform the first light beam into a first image signal. The second light-source unit is configured to provide a second light beam. The second digital micro-mirror unit is configured to receive the second light beam and transform the second light beam into a second image signal. The first prism is configured to receive and reflect the first and second image signals. The first wide-angle lens and the second wide-angle lens are configured to receive and project the first and second image signals reflected from the first prism respectively.